(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ABFERO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ABFERO

ST13

US500000079361488

Class

5

Filing

79361488

Registration

7435408

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

04/24/2026

Trademark type

Word

Nice classes

5

Filing date

11/28/2022

Registration date

07/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2024

Last transaction

04/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

65

Owner location

DK-4300 Holbæk, DK

Examiner

MESSICK, TABITHA LEE

Current location

Historical data usage

Holders and representatives

Holders

Pharmacosmos Holding A/S
Pharmacosmos Holding A/S

Representatives

Shannon Marie McKeon Dykema Gossett PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; veterinary preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in animals; dietary supplements for human beings and animals ; iron preparations for pharmaceutical use being nutritional supplements; iron preparations for veterinary use being nutritional supplements; iron preparations as dietary supplements; diagnostic preparations for medical and veterinary purposes; molecular weight testing reagents for diagnostic purposes; medicinalpharmaceutical and veterinary preparations for parenteral administrationin particular oralintravenousintramuscular and subcutaneous for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for medical and pharmaceutical purposesfor the treatment and prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for veterinary purposesfor the treatment and prevention of iron deficiency and/or anaemia or of iron overload in humans * all aforementioned goods for human use only *

Publications

History of USPTO decisions and trademark events.

39 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/23/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/06/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/06/2026

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

03/31/2026

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

03/10/2026

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

03/09/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/09/2026

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/28/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/10/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/20/2024

FIMP

FINAL DISPOSITION PROCESSED

12/20/2024

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

12/20/2024

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

11/08/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/09/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/23/2024

GPNX

NOTIFICATION PROCESSED BY IB

04/23/2024

PUBO

PUBLISHED FOR OPPOSITION

04/23/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

03/13/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/13/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

03/13/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/13/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/12/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/12/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/12/2024

RFNT

REFUSAL PROCESSED BY IB

09/13/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/21/2023

RFRR

REFUSAL PROCESSED BY MPU

08/21/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/27/2023

CNRT

NON-FINAL ACTION WRITTEN

07/26/2023

DOCK

ASSIGNED TO EXAMINER

07/18/2023

MAFR

APPLICATION FILING RECEIPT MAILED

02/07/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/03/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/02/2023

Continuous trademark protection

Get notified about every new filing that threatens ABFERO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.